Overview |
bs-2409R-FITC |
Amphiphysin Polyclonal Antibody, FITC Conjugated |
IF(IHC-P), IF(IHC-F), IF(ICC) |
Rat |
Human, Mouse, Dog, Cow, Horse, Chicken, Rabbit |
Specifications |
FITC |
Rabbit |
KLH conjugated synthetic peptide derived from human Amphiphysin |
101-200/695 |
Polyclonal |
IgG |
1ug/ul |
Purified by Protein A. |
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target |
273 |
Cytoplasm, Cell membrane |
Amphiphysin; Amp; AMPH 1; AMPH1; Amphiphysin Stf-Man syndrome with breast cancer 128kD autoantigen; Amphiphysin Stf-Man syndrome with breast cancer 128kDa autoantigen; Amphiphysin I; CG8604; Damp; dAmph; Dmel\CG8604; HGNC:471; MGC49429; Stf man syndrome with breast cancer 128kD autoantigen; Stf man syndrome with breast cancer 128kDa autoantigen; AMPH_HUMAN. |
Amphiphysin is associated with the cytoplasmic surface of synaptic vesicles. A subset of patients with stiff man syndrome who were also affected by breast cancer are positive for auto against this protein. Alternate splicing of this gene results in two transcript variants (Amphiphysin 1 and Amphiphysin 2) encoding different isoforms. Additional splice variants have been described, but their full length sequences have not been determined. |
Application Dilution |
IF(IHC-P) |
1:50-200 |
IF(IHC-F) |
1:50-200 |
IF(ICC) |
1:50-200 |